Hypertension Vaccine
Vaccine elicits anti-angiotensin I antibodies in hypertensive subjects
Published in Vaccine Weekly, October 20th, 2004
According to a study from France, "Immunization against components of the renin-angiotensin system offers a potential alternative to daily medication in some patients with hypertension or heart failure. Our primary objective was to determine whether a sustained antibody titer to Ang I (angiotensin I) can be achieved in hypertensive patients. The secondary objective was to determine whether the antibodies block the renin system."
"Patients (n=27) with essential hypertension responsive to an ACEi (angiotensin-converting enzyme...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2004-10-20)
More Articles from Vaccine Weekly
- AIDS/HIV Vaccine
Site mapping in HIV genome may provide new approach to vaccine design - Anthrax Vaccine
DNA vaccine protects mice against challenge anthrax STI spores - Microencapsulation
Microspheres induce adult-like CD8+ cytotoxic T cell responses - Prostate Cancer Vaccine
Antigen-derived peptides induce CTLs in prostate cancer patients - AIDS/HIV Vaccine
HLA class I serotypes important in vaccine efficacy assessments - AIDS/HIV Vaccine
Parenteral and mucosal DNA vaccination enhances SHIV infection control - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
